Original document(6 pages)  中文版
    The invention relates to a method to extract naringin monomer from pomelo (like Shatian pomelo), slicing up or crush pomelo, extracting by water for one or many times, filtering and combining filtrates; condensing the filtrate into extract, applying the extract on column after alcohol deposition or directly, making column separation, and eluting by organic solvent; volatilize the solvent from the eluent to obtain rough product; then recrystallizing for many times to obtain naringin crystal. The extraction yields of naringin from Shatian pemelo are all above 85% and the naringin monomer content in the obtained naringin sample reaches above 98%.
Application Number
申请号
03146997 Application Date
申请日
2003.09.29
Title 名称 Method for extracting shaddock ped aglycone from shaddock
Publication Number
公开号
1528773 Publication Date
公开日
2004.09.15
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07H1/08,C07H17/07
Applicant(s) Name
申请人
Zhongshan Univ.
Address 地址 510275
Inventor(s) Name 发明人 Su Weiwei, Fang Tiezheng
Attorney & Agent 代理人

  
Naringin used in preparing medicine for curing acute and chronic bronchitis
Method for extracting naringin
Health care food for regulating immunity, antioxidation and its preparing method
'Huajuhong' preparation and its preparing process
Method for extracting quercetin-7-0-rhamnoside
Method for preparing alpha-interferon plasmid DNA-liposome preparation
Method for constituting finger-print pyrogram of white atracty lodes and its standard finger-print pyrogram
Method for constituting TLC finger-print pyrogram of hypericum-japonicum medicinal herbs and its standard finger-print pyrogram
Application of naringin in preparing medicine for supporting treatment of SARS
Medicine composition for treating diabetes and its preparation
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.